tbuckley/cabot-search huggingface dataset:
Connective Tissues: Transactions of the Second Conference, May 24-25, 1951, New York, N. Y.
Authors: Charles Ragan
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma
Authors: Arne Kolstad, Ulf Madsbu, Jostein Dahle, Caroline Stokke, Tore Bach-Gansmo, Ayca Muftuler Løndalen, Jon Erik Holtedahl, Mona Elisabeth Revheim, Øyvind Bruland, Bjørg Bolstad, Nils Bolstad, Anne Tierens, Roy Hartvig Larsen, Jan Alan Alfheim, Jan Delabie, Spetalen Signe, Martin Erlanson, Stine Nygaard Rudå, Harald Holte
Journal: Blood (2014)
Abstract 14035: High Levels of Antibodies Against Phosphorylcholine and Modified LdL in Combination Confers 8-9 Times Increased Protection Against Atherosclerosis Increase Among Patients With Hypertension: Possible Implications for Immune Therapy
Authors: Johan Frostegard, Jun Su, Ulf de Faire
Journal: Circulation (2011)

Objective: To determine combinations of antibodies of IgM isotype against phosphorylcholine (anti-PC) and modified forms of low density lipoprotein (malondialdehyde modified (anti-MDALDL) or oxidiz...
Prospective Study of Ambient Particulate Matter Exposure and Risk of Pulmonary Embolism in the Nurses’ Health Study Cohort
Authors: Vivian C. Pun, Jaime E. Hart, Christopher Kabrhel, Carlos A. Camargo, Andrea A. Baccarelli, Francine Laden
Journal: Environmental Health Perspectives (2015)

Pulmonary embolism (PE) is the most serious manifestation of venous thromboembolism and a leading cause of sudden death. Several studies have suggested associations of venous thromboembolism with short-term particulate matter (PM) exposure; evidence on long-term PM and traffic exposure is mixed.We examined the association of long-term exposure to PM2.5, PM2.5-10, and PM10 (PM with diameter of ≤ 2.5, 2.5-10, and ≤ 10 μm) and distance to roadways with overall incident PE and with PE subtypes in a cohort of U.S. women.The study included 115,745 women from the Nurses' Health Study, followed from 1992 through 2008. Incident PE cases were self-reported biennially. Nonidiopathic PE were cases for which the medical record revealed an underlying health condition related to PE (i.e., surgery, trauma, or malignancy); idiopathic PE were cases with no such history. We used spatiotemporal models combining spatial smoothing and geographic covariates to quantify exposure at residential addresses, and Cox proportional hazards models to calculate hazard ratios (HR) and 95% confidence intervals (CIs).PM2.5 averaged over 1 month (HR = 1.22; 95% CI: 1.04, 1.44) or 12 months (HR = 1.17; 95% CI: 0.93, 1.48) was associated with incident PE, after adjusting for known risk factors and PM2.5-10. Equivalent analyses restricted to PE subtypes showed a positive association for PM2.5 with nonidiopathic PE, but not with idiopathic PE. We did not find evidence of an association between distance to roadways and PE risk.We provide evidence that PM in the prior 1 and 12 months is associated with PE risk. Our results also suggest that women with underlying health conditions may be more susceptible to PE after PM exposure.
Cardiac Pacing and Electrophysiology
Authors: Nabil El-Sherif, Philip Samet
Journal: Annals of Internal Medicine (1992)

The new edition begins with the basic aspects of cardiac electrophysiology in adults and children, and proceeds to cover all aspects of pacemaker implantation for the management of cardiac arrhythmias. It emphasizes the clinical use of pacemakers, rather than hardware or basic sciences. It also covers in depth antiarrhythmic agents and catheter ablation techiques. Over 50 recognised authorities contribute to this comprehensive and critical review.
Erythropoiesis. Proceedings of the Fourth International Conference on Erythropoiesis.
Authors: Kiku Nakao, James W. Fisher, Fumimaro Takaku
Journal: Annals of Internal Medicine (1976)

Erythropoiesis : proceedings of the fourth International Conference on Erythropoiesis , Erythropoiesis : proceedings of the fourth International Conference on Erythropoiesis , کتابخانه مرکزی دانشگاه علوم پزشکی ایران
How the Mind Cures. A Consideration of the Relationship Between Your Outside and Your Inside Individualities and the Influence They Exercise Upon Each Other for Your Physical and Mental Welfare.
Authors: George Frank Butler
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 15254: Time Difference between Onset of Mitral Inflow and Onset of Early Diastolic Mitral Annulus Velocity predicts Left Ventricular End-diastolic Pressure: Assessment by Dual Doppler Echocardiography
Authors: Kenya Kusunose, Hirotsugu Yamada, Susumu Nishio, Noriko Tomita, Shuji Hayashi, Sachiko Bando, Sahika Hisaoka, Toshiyuki Niki, Koji Yamaguchi, Yoshio Taketani, Takashi Iwase, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike, Masataka Sata
Journal: Circulation (2010)
The Biology of the Individual: An Investigation of the Most Recent Advances
Authors: J. Ramsay Hunt, Thomas K. Davis, Angus M. Frantz
Journal: JAMA (1935)

This volume is a compilation of the proceedings of the fourteenth annual meeting of the Association for Research in Nervous and Mental Disease. The papers have been published in full, together with questions and answers as submitted by the commission and members of the association. The first half of the book contains papers on the fundamental factors of heredity, growth, environment and various problems of constitution. This section is particularly instructive and includes such acknowledged masters in their respective fields as Smith Ely Jelliffe, on historical notes on constitution and individuality; C. R. Davenport, on body build and its inheritance; William James, on morphologic form and its relation to reflex action and behavior; T. Wingate Todd, on the progress of physical maturity and mental expansion in childhood; Arnold Gesell, on the ontogenetic patterning of infant behavior; Lewellys Barker, on constitution and internal medicine; Walter Timme, on endocrine aspects of constitution;
Abstract 15914: Mitochondrial Short Form Sulfonylurea Receptors-2A Splice Variant Protects Hearts From Ischemia Reperfusion Injury.
Authors: Nitin T Aggarwal, Nian-Qing Shi, Jonathan C Makielski
Journal: Circulation (2010)

Sulfonylurea receptor-2 is a subunit of ATP-sensitive K-channels (KATP) that have been implicated in protecting hearts from ischemia reperfusion (I/R) injury. Surprisingly, SUR2 knockout (SUR2KO) male mice are protected against I/R injury. A 55kDa intra-exonic splice variant of SUR2A (SUR2A-55) unique to mitochondrial membrane fractions forms functional KATP channels and is more abundant in mitochondria of SUR2KO mice than in wild type (Wt). We hypothesized that increased expression of SUR2A-55 protects hearts from I/R injury. We established three transgenic (Tg+) mouse lines with 1, 3 or >5 copies of the SUR2A-55 transgene using a cardiac specific α-MHC promoter in the Wt background. Cardiac specific mitochondrial expression of SUR2A-55 increased in the order Wt < Tg+1 < Tg+3 < Tg+5 by immunoblotting and RT-PCR. Survival of the Tg+5 mice was low presumably due to toxic over-expression. After 30 min ischemia and 24 h reperfusion, the infarct sizes in Tg+1 (10±3%, n=11, p<0.05) and Tg+3 (7±3%, n=9, p<0.001...
Insanity —Its Classification, Diagnosis and Treatment.
Authors: Edward Charles Spitzka
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
How To Do It: Set up and run an objective structured clinical exam
Authors: C. Selby, L. Osman, M. Davis, M. Lee
Journal: BMJ (1995)

Objective structured clinical exams are increasingly used as a way of assessing a range of clinical skills at both undergraduate and postgraduate level. To those planning to introduce such assessments, this article provides basic guidance on their development and structure and the personnel required. For those already using the assessments, our article may provide new ideas or be the impetus for an exchange of ideas. For those who are facing such formal assessment as candidates, we hope this article shows the efforts that are made to achieve the necessary structure and objectivity in this type of examination.
Coronary Artery Stenosis
Authors: K. Lance Gould
Journal: Annals of Internal Medicine (1991)

Anatomic and functional characteristics of coronary artery stenosis physiology of coronary circulation methods for pressure-flow analysis and arteriography interactions with the coronary vascular bed phasic pressure flow and fluid dynamic analysis phasic pressure flow and arteriographic geometry collapsing stenoses coronary flow reserve quantitative coronary arteriography reversal by risk factor modication positron emission tomography of the heart prinicples of cardiac PET PET perfusion imaging quantitation of PET perfusion images coronary collateral function assessed by PET assessing myocardial infarction, ischemia and viability PET compared to other imaging modalities accuracy and performance of the positron scanner economics of cardiac PET radiation burden, facilities and regulatory status clinical case studies with PET.
History of the New Hampshire Surgeons in the War of the Rebellion.
Authors: Granville Conn
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Efficacy and Safety of Lenalidomide (LEN) Versus Placebo (PBO) in RBC-Transfusion Dependent (TD) Patients (Pts) with IPSS Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (MDS) without Del(5q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (ESAs): Results from a Randomized Phase 3 Study (CC-5013-MDS-005)
Authors: Valeria Santini, Antonio Almeida, Aristoteles Giagounidis, Stephanie Gröpper, Anna Jonasova, Norbert Vey, Ghulam J. Mufti, Rena Buckstein, Moshe Mittelman, Uwe Platzbecker, Ofer Shpilberg, Ron Ram, Consuelo del Canizo, Norbert Gattermann, Keiya Ozawa, Jim Zhong, Francis Séguy, Albert Hoenekopp, C.L. Beach, Pierre Fenaux
Journal: Blood (2014)
Phase I study of capecitabine combined with weekly carboplatin and intensity modulated radiation therapy (IMRT) for treatment of locally advanced squamous cell carcinomas of the head and neck (HNSCC)
Authors: C. Y. Thomas, P. Read, K. Sheng, D. Bliesner, P. Levine, J. Reibel
Journal: Journal of Clinical Oncology (2006)

15522 Background: Chemoradiotherapy (CRT) programs for locally advanced HNSCC that reduce toxicity but maintain efficacy are needed. Methods: A two-step phase I trial to determine the maximum tolerated dose (MTD) of capecitabine combined with fixed dose carboplatin, given prior to and during concomitant IMRT. Start dose of capecitabine =1500 mg/m 2 /d p.o. BID days 1–14 and 22–35 with carboplatin AUC =2 IV weekly x 6. With IMRT, the doses were adjusted to 1000 mg/m 2 /d and AUC =1.5, respectively. Parotid-sparing IMRT = 50 and 45 Gy/25 fractions to gross disease (GD) and low risk nodes, respectively; 3D conformal boost of 20 Gy/10 fractions to GD. Dose limiting toxicity (DLT) defined as ANC &lt;750, ≥ grade 3/4 thrombocytopenia or selected non-hematologic toxicities. Results: 11 patients (pts) with stage III/IV (T2–4,N1–2C) HNSCCs of the oropharynx (7), oral cavity (2), both (1), or hypopharynx (1) were studied. 10/9 pts evaluable for toxicity after induction/concomitant chemotherapy, respectively; 2 pts had early disease progression (d22 and 43). During radiation, the MTD for capecitabine established as 825 mg/m 2 /d. At start dose, 2/3 pts developed thrombocytopenia as DLT; CRT-related toxicities = grade 3 mucositis (3), dysphagia (3), fatigue (1), anemia (1), and dermatitis (1). For induction chemotherapy, DLTs seen in 0/3 pts at capecitabine =1750 mg/m 2 and 1/6 at lower doses (grade 4 diarrhea; no other Gr3/4 drug-related toxicities). Response of primary (or neck) tumors to induction: CR 3 (3), PR 6 (3), SD 1 (3), and PD 2 (2). After CRT, 8/9 pts achieved CR and are alive without disease (mean follow-up 6 months). Conclusions: Capecitabine 825 mg/ m 2 /d and carboplatin AUC =1.5 weekly given on the described schedule and in combination with IMRT produce moderate toxicity and a high complete response rate in stage III/IV HNSCC pts that received the same drugs as induction therapy. The latter combination was also well tolerated and had anti-tumor activity (capecitabine Y=1500–1750 mg/m 2 /d). Additional studies are warranted to determine if these regimens provide an effective but less toxic alternative to cisplatin or taxane-based CRT programs. Supported in part by Bristol-Myers-Squibb. No significant financial relationships to disclose.
Abstract 17825: Abnormal Morphology of Skeletal Muscle Myofibers Is Associated With Limb Dysfunction in Peripheral Arterial Disease Patients
Authors: Panagiotis Koutakis, Iraklis I Pipinos, Kim Cluff, Jonathan R Thompson, Duy Ha, Evlampia Papoutsi, Stanley A Swanson, Zhen Zhu, Kyung-Soo Kim, Sara Myers, Shane Wurdeman, Nicholas Stergiou, Jason M Johanning, Rodney D McComb, George P Casale
Journal: Circulation (2013)

Introduction: Peripheral arterial disease (PAD) affects approximately 8.5 million Americans and is characterized by the formation of atherosclerotic plaques that limit blood flow to the legs. Degra...
Evidence based patient information
Authors: A. Coulter
Journal: BMJ (1998)

Information in Practice pp 263, 264 

Leaflets and other information packages (video and audio tapes, computer programs, and websites) have long been seen as integral to educational strategies designed to promote health, persuade people to adopt healthy lifestyles, and increase uptake of screening. They have also been developed to educate patients in self care of such chronic conditions as arthritis, hypertension, stress related psychological problems, gastrointestinal diseases, and back pain, and how to take medicines correctly. There is now growing interest in providing information to support patients' participation in choosing treatments and deciding on strategies for managing their health problems.1 Much well intentioned effort goes into developing such material, but good intentions are not enough to guarantee quality and usefulness, as two papers in this week's issue show (pp 263, 264). 23 If patients …
Abstract 16777: Serial Angiographic Follow-Up after Successful Implantation of Sirolimus, Paclitaxel and Everolimus-Eluting Stent for Chronic Total Occlusions: Multicenter Registry in Asia
Authors: Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo H Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana Tansuphaswadikul
Journal: Circulation (2010)

Purpose: To evaluate the long-term efficacy of Sirolimus-eluting stent (SES), Paclitaxel-eluting stent (PES) and Everolimus-eluting stent (EES) on the outcome of patients with chronic total occlusions (CTO). Methods: A total of 298 patients with 326 CTO lesions (male 72.1%, mean age 69.8 yrs, LAD 49.7%, LCX 21.5%, RCA 26.7%, Others 2.1%) were treated with SES (102 patients 118 lesions, mean lesion length 36.1±12.9 mm, mean stent length 41.7±15.6 mm) EES (88 patients 94 lesions, mean lesion length 34.2±13.8 mm, mean stent length 40.1±14.8 mm) and PES (108 patients 114 lesions, mean lesion length 38.5±12.8 mm, mean stent length 43.9±19.5 mm). We conducted follow-up coronary angiogram in all patients after successful implantation of SES, PES and EES (9, 12, 18, 24 months respectively) Results: See table for clinical results. Conclusions: There is a different timing of late catch up phenomenon (late lumen loss) of SES, EES and PES (SES: 12–18 months, EES: 12–18 months and PES: 9–12 months) after successful im...
Abstract 977: Baseline Troponin Levels Predict 30 Day CV Mortality in STEMI Independent of Clinical and Electrocardiographic Factors: Analysis from CLARITY-TIMI 28
Authors: Matthew W Sherwood, David A Morrow, Benjamin M Scirica, Songtao Jiang, Christoph Bode, Nader Rifai, Robert E Gerszten, Christopher P Cannon, Eugene Braunwald, Marc S Sabatine
Journal: Circulation (2008)

Background: Cardiac troponin is the preferred biomarker for risk stratification in non-ST-elevation ACS. The incremental prognostic utility of the initial magnitude of troponin elevation and its va...
Abstract 15348: CD40 Deficiency Aggravates Diet-Induced Obesity, Adipose Tissue Inflammation, and Insulin Resistance in Mice
Authors: Dennis Wolf, Felix Jehle, Andrey Lozhkin, Ingo Hilgendorf, Christoph Bode, Karlheinz Peter, Andreas Zirlik
Journal: Circulation (2011)

Background: Infiltration of immune cells, such as T-cell subsets, is a hallmark of adipose tissue inflammation and the metabolic syndrome. T-cell functioning potently depends on co-stimulatory path...
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy
Authors: Yasuyuki Arai, June Takeda, Kazunari Aoki, Tadakazu Kondo, Satoshi Takahashi, Yasushi Onishi, Yukiyasu Ozawa, Nobuyuki Aotsuka, Yasuji Kouzai, Hirohisa Nakamae, Shuichi Ota, Chiaki Nakaseko, Hiroki Yamaguchi, Koji Kato, Yoshiko Atsuta, Akiyoshi Takami
Journal: Blood (2015)
Efficacy of electroacupuncture for bone metastatic cancer patients with neuropathic pain: A randomized controlled trial
Authors: L. Sima, C. Yin
Journal: Journal of Clinical Oncology (2009)

9534 Background: Bone metastatic lung cancer or breast cancer pts often have neuropathic pain which has poor reaction to opioids. A clinical trial is to investigate efficacy of electroacupuncture (EA) in cancer pts with neuropathic pain. Methods: Inclusion criteria were: bone metastatic lung cancer or breast cancer pts at least one of the symptoms as burning pain, shooting pain, dysesthesias, or allodynia; numerical rating scale (NRS) of pain intensity &gt;=4.0; stable dose of opioids for at least 72 hours. Exclusion criteria were: chemotherapy or radiotherapy from 15 days before or during the study. Hormone or adjuvant therapy could be started before the study, but the dose could not be changed afterwards. Opioids could be increased step by step according to the pain. EA was manipulated with low-frequency (2 Hz) and high-frequency (100 Hz) dense-disperse waves alternatively, 30 minutes per day, 5-day therapy with 2-day interval, 3 weeks continuously. Acupoints were selected as ST36, SJ3, SJ5, LI3, LI4 bilateral. Controlled group accepted non-acupoint treatment close the right acupoint. Results: Ninety pts with neuropathic pain participated in a randomized, controlled design trial from 2006 to 2008. Overall, 45 pts accepted EA treatment and 34 completed the study. 45 pts accepted controlled and 32 completed. There was no difference of initial NRS which was 6.3±2.1 in EA group and 7.2±1.8 in controlled, p = 0.0669. Analysis showed a significant difference of NRS between EA group (3.2±1.7) and controlled (5.4±2.2) at the end of survey, p &lt; 0.0001. The decrease in NRS was significantly higher in the EA group compared to the controlled (3.2±1.7 vs. baseline, p &lt; 0.0001; 5.4±2.2 vs. baseline, p = 0.0007). Mean analgesics consumption variety in EA group was as follows: transdermal fentanyl increased by 51.2% (16 pts) and 77.3% (21 pts) in EA and controlled, p = 0.0005. Oxycodone increased by 85.5% (18 pts) and 115.6% (11 pts) in EA and controlled, p = 0.0183. Functional Assessment of Cancer Therapy-General (FACT-G) scale had no difference at the beginning, while it were 102±18 and 85±12 in EA group and controlled at the end of survey, p &lt; 0.0001. Conclusions: EA can alleviate neuropathic pain of bone metastatic cancer pts, decrease the analgesics consumption, and promoting quality of life. No significant financial relationships to disclose.